Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Stryker Corporation (SYK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
266.32+2.47 (+0.94%)
At close: 4:03PM EDT
263.15 -3.17 (-1.19%)
After hours: 05:15PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close263.85
Open265.79
Bid265.84 x 800
Ask266.40 x 800
Day's Range263.48 - 266.50
52 Week Range196.09 - 281.16
Volume1,855,482
Avg. Volume1,159,656
Market Cap100.428B
Beta (5Y Monthly)0.99
PE Ratio (TTM)48.80
EPS (TTM)5.46
Earnings DateOct 28, 2021
Forward Dividend & Yield2.52 (0.95%)
Ex-Dividend DateSep 29, 2021
1y Target Est287.64
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-8% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SYK

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Stryker Corporation
    Weekly Stock ListConsumers are now more willing to spend on lifestyle enhancements along with necessary spending on life-saving treatments. In addition, the survival of the Affordable Care Act has kept the ranks of insured U.S. citizens above the historical average, further increasing consumer spending on healthcare services and products. Meanwhile, companies with experience in diagnostic testing, vaccines, and antiviral medicines, as well as suppliers of protective equipment and other hospital products, should benefit from efforts to contain the coronavirus pandemic. The sector accounts for 13.0% of the S&P 500, and includes companies in the pharmaceuticals, medical devices, healthcare services, and insurance industries. The sector is underperforming the market thus far in 2021, with a gain of 12.9%. We think the sector should account for 15-17% of diversified portfolios. Here is how we use our analysts' Financial Services sector ideas in our Focus List and Model Portfolios. All stocks are rated BUY at Argus.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • Insider Monkey

    Top 10 Stock Picks of Terry Smith’s Fundsmith LLP

    In this article, we discuss the top 10 stock picks of Terry Smith’s Fundsmith LLP. If you want to skip our detailed analysis of Smith’s history, investment philosophy, and hedge fund performance, go directly to the Top 5 Stock Picks of Terry Smith’s Fundsmith LLP. Terry Smith, a renowned British investor often referred to as […]

  • Motley Fool

    2 Top Healthcare Stocks to Buy for the Long Haul

    When the legendary chairman and CEO of Berkshire Hathaway, Warren Buffett, writes his letter to shareholders each year, the investment world often stops to glean a few lessons from the Oracle of Omaha. One of the most memorable messages came in his 1996 Chairman's Letter, in which Buffett advised, "If you aren't willing to own a stock for ten years, don't even think about owning it for ten minutes." Two healthcare stocks that investors can confidently buy for the long haul are Stryker (NYSE: SYK) and CVS Health (NYSE: CVS).

  • GlobeNewswire

    Stryker to host analyst meeting

    Kalamazoo, Michigan, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site. To listen to the meeting via phone dial (844) 200-6205 (domestic) or (929) 526-1599 (international)

Advertisement
Advertisement